Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Restoring airway surface liquid in cystic fibrosis.

Ratjen F.

N Engl J Med. 2006 Jan 19;354(3):291-3. No abstract available.

PMID:
16421371
2.

Mucus clearance and lung function in cystic fibrosis with hypertonic saline.

Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC.

N Engl J Med. 2006 Jan 19;354(3):241-50.

3.

Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis.

Robinson M, Hemming AL, Regnis JA, Wong AG, Bailey DL, Bautovich GJ, King M, Bye PT.

Thorax. 1997 Oct;52(10):900-3.

4.

Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agents.

Hirsh AJ.

Adv Drug Deliv Rev. 2002 Dec 5;54(11):1445-62. Review.

PMID:
12458154
5.

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.

Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group.

N Engl J Med. 2006 Jan 19;354(3):229-40.

6.

Osmolytes and ion transport modulators: new strategies for airway surface rehydration.

Goralski JL, Boucher RC, Button B.

Curr Opin Pharmacol. 2010 Jun;10(3):294-9. doi: 10.1016/j.coph.2010.04.003. Epub 2010 May 1. Review.

PMID:
20439165
7.

Inhaled hypertonic saline as a therapy for cystic fibrosis.

Elkins MR, Bye PT.

Curr Opin Pulm Med. 2006 Nov;12(6):445-52. Review.

PMID:
17053496
8.

Hypertonic saline for cystic fibrosis.

Zarogiannis S, Hatzoglou C, Gourgoulianis K.

N Engl J Med. 2006 Apr 27;354(17):1848-51; author reply 1848-51. No abstract available.

PMID:
16642590
9.

Hypertonic saline and PEP: is it worth a try?

O'Malley CA.

Respir Care. 2011 Jun;56(6):886-7. doi: 10.4187/respcare.01358. No abstract available.

10.

Hypertonic saline for cystic fibrosis.

Aziz I, Kastelik JA.

N Engl J Med. 2006 Apr 27;354(17):1848-51; author reply 1848-51. No abstract available.

11.

Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis.

Laube BL, Sharpless G, Carson KA, Kelly A, Mogayzel PJ Jr.

BMC Pulm Med. 2011 Sep 6;11:45. doi: 10.1186/1471-2466-11-45.

12.

[Inhaled therapies for cystic fibrosis].

Lahzami S, Nicod LP.

Rev Med Suisse. 2011 Nov 23;7(318):2285-8. Review. French.

PMID:
22400363
13.

Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis.

Robinson M, Regnis JA, Bailey DL, King M, Bautovich GJ, Bye PT.

Am J Respir Crit Care Med. 1996 May;153(5):1503-9.

PMID:
8630593
14.

Hypertonic saline for cystic fibrosis.

Kuver R, Lee SP.

N Engl J Med. 2006 Apr 27;354(17):1848-51; author reply 1848-51. No abstract available.

PMID:
16642591
15.

Nebulized hypertonic saline via positive expiratory pressure versus via jet nebulizer in patients with severe cystic fibrosis.

O'Connell OJ, O'Farrell C, Harrison MJ, Eustace JA, Henry MT, Plant BJ.

Respir Care. 2011 Jun;56(6):771-5. doi: 10.4187/respcare.00866. Epub 2011 Feb 11.

16.

Hyaluronic acid improves "pleasantness" and tolerability of nebulized hypertonic saline in a cohort of patients with cystic fibrosis.

Buonpensiero P, De Gregorio F, Sepe A, Di Pasqua A, Ferri P, Siano M, Terlizzi V, Raia V.

Adv Ther. 2010 Nov;27(11):870-8. doi: 10.1007/s12325-010-0076-8. Epub 2010 Oct 14.

PMID:
20953746
17.

The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?

Bilton D, Stanford G.

Curr Opin Pulm Med. 2014 Nov;20(6):601-6. doi: 10.1097/MCP.0000000000000104. Review.

PMID:
25221855
18.

The facilitating effect of hypertonic saline on resolution of airway inflammation in cystic fibrosis.

Reeves EP, McElvaney NG.

Am J Respir Crit Care Med. 2012 Jan 15;185(2):226-7. No abstract available.

PMID:
22351955
19.

Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.

Eng PA, Morton J, Douglass JA, Riedler J, Wilson J, Robertson CF.

Pediatr Pulmonol. 1996 Feb;21(2):77-83.

PMID:
8882210
20.

Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.

Subbarao P, Balkovec S, Solomon M, Ratjen F.

Pediatr Pulmonol. 2007 May;42(5):471-6.

PMID:
17436328

Supplemental Content

Support Center